About: AMR
AMR incentives could be next big EU opportunity, pharma boss says
Europe could become the first region worldwide to incentivise the fight anti-microbial resistance (AMR), Nathalie Moll, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), told EURACTIV in an interview.
Commission: Third countries should meet EU antibiotics requirements on animal exports
Non-EU countries that export animals and animal products to the bloc will have to abide by new rules on veterinary medicines when it comes to the use of antibiotics, according to the European Commission.
Innovation in animal health: Sifting the tangible actions from the political ideas
Over the past fifty years, the EU has done a stellar job in moving from a very fragmented national approach to animal disease control to a progressively more harmonised system of animal health measures, disease surveillance, diagnosis and control, writes Roxane Feller.
Expert: Animal health innovations will benefit both farming and society
An innovation-driven approach – ranging from vaccination to other health management solutions and appropriate biosecurity measures – will ensure more sustainable future livestock farming and protection of public health, as animal diseases do not recognise borders, Roxane Feller told EURACTIV.com.
Radical hospital hygiene reform needed in Europe
Europe is losing the fight against antimicrobial resistance (AMR). By 2050, AMR could cause more deaths than cancer; the economic damage will be on par with the 2008 economic crisis.
Antimicrobial resistance set to become bigger killer than cancer by 2050
Antimicrobial resistance is a ticking time bomb. Ahead of the European Antibiotic Awareness Day on 18 November, the EU and public health stakeholders are aiming to raise awareness of this issue and make it a policy priority in the member states.